Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon T Giles

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Arthritis and Rheumatism|July 1, 2010
Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristicsJon T Giles, Matthew Allison, Roger S Blumenthal, et al.
Arthritis Care & Research|October 4, 2016
Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid ArthritisLaura Geraldino-Pardilla, Jon T Giles, Jeremy Sokolove, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 24, 2024
Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritisHadil Zureigat, Giovanni Civieri, Shady Abohashem, et al.
Arthritis and Rheumatism|June 3, 2008
Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapiesJon T Giles, Shari M Ling, Luigi Ferrucci, et al.
Rheumatology and Therapy|July 28, 2021
Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective AnalysisJon T Giles, Lee S Simon, Janet Pope, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled TrialJon T Giles, Naveed Sattar, Sherine Gabriel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2014
Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosisJon T Giles, Stamatina Danielides, Moyses Szklo, et al.
RMD Open|January 16, 2021
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritisJon T Giles, Alexis Ogdie, Juan J Gomez Reino, et al.
Rheumatology (Oxford, England)|November 8, 2021
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometryMichail K Alevizos, Sonye K Danoff, Dimitrios A Pappas, et al.
Annals of the Rheumatic Diseases|May 30, 2013
Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung diseaseJon T Giles, Sonye K Danoff, Jeremy Sokolove, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Arthritis and Rheumatism|July 1, 2010
Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristicsJon T Giles, Matthew Allison, Roger S Blumenthal, et al.
Arthritis Care & Research|October 4, 2016
Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid ArthritisLaura Geraldino-Pardilla, Jon T Giles, Jeremy Sokolove, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 24, 2024
Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritisHadil Zureigat, Giovanni Civieri, Shady Abohashem, et al.
Arthritis and Rheumatism|June 3, 2008
Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapiesJon T Giles, Shari M Ling, Luigi Ferrucci, et al.
Rheumatology and Therapy|July 28, 2021
Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective AnalysisJon T Giles, Lee S Simon, Janet Pope, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled TrialJon T Giles, Naveed Sattar, Sherine Gabriel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2014
Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosisJon T Giles, Stamatina Danielides, Moyses Szklo, et al.
RMD Open|January 16, 2021
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritisJon T Giles, Alexis Ogdie, Juan J Gomez Reino, et al.
Rheumatology (Oxford, England)|November 8, 2021
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometryMichail K Alevizos, Sonye K Danoff, Dimitrios A Pappas, et al.
Annals of the Rheumatic Diseases|May 30, 2013
Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung diseaseJon T Giles, Sonye K Danoff, Jeremy Sokolove, et al.
Pageof 16